171 related articles for article (PubMed ID: 3010578)
1. Contribution of arachidonic acid metabolites to atherosclerosis.
Dembińska-Kieć A; Gryglewski RJ
Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
[TBL] [Abstract][Full Text] [Related]
2. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
3. The role of prostacyclin in vascular tissue.
Moncada S; Vane JR
Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
[TBL] [Abstract][Full Text] [Related]
4. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
5. Prostacyclin in physiology and pathophysiology.
Vane JR; Bunting S; Moncada S
Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
[No Abstract] [Full Text] [Related]
6. Regulation of phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
[No Abstract] [Full Text] [Related]
7. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
Baluda VP; Sushkevich GN; Lukoianova TI
Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
[No Abstract] [Full Text] [Related]
8. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
9. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
Basevich VV; Mevkh AT; Varfolomeev SD
Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
[TBL] [Abstract][Full Text] [Related]
10. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Schafer AI; Crawford DD; Gimbrone MA
J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
[TBL] [Abstract][Full Text] [Related]
11. The role of prostaglandins in platelet function.
Burch JW; Majerus PW
Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883
[No Abstract] [Full Text] [Related]
12. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
13. [Kinetic model of a multienzyme system of blood prostanoid synthesis. I. Mechanism of stabilization of thromboxane and prostacyclin levels].
Varfolomeev SD; Mevkh AT; Gachok VP
Mol Biol (Mosk); 1986; 20(4):957-67. PubMed ID: 3093845
[TBL] [Abstract][Full Text] [Related]
14. [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)].
Oelz O
Ther Umsch; 1979 Oct; 36(10):882-8. PubMed ID: 119331
[No Abstract] [Full Text] [Related]
15. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
[TBL] [Abstract][Full Text] [Related]
16. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
17. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism.
Defreyn G; Machin SJ; Carreras LO; Dauden MV; Chamone DA; Vermylen J
Br J Haematol; 1981 Sep; 49(1):29-41. PubMed ID: 6268139
[TBL] [Abstract][Full Text] [Related]
18. Mechanism underlying the inhibition of platelet aggregation by eicosapentaenoic acid and its metabolites.
Needleman P; Sprecher H; Whitaker MO; Wyche A
Adv Prostaglandin Thromboxane Res; 1980; 6():61-8. PubMed ID: 6247894
[No Abstract] [Full Text] [Related]
19. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
